Drawing for PHYTOLAND

USPTO serial 79053762

PHYTOLAND

Reviewed by CopyMark Law Group

Reg. 3606257Status 404
Filing date
Status date
Registration date
Apr 14, 2009
Examiner
HACK, ANDREA R
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHYTOLAND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities, neoplasia, breast neoplasm, breast cancer, mamma, mastopathy, mastodynia, premenstrual syndrome, climateric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, vaginal discomfort due to menopausal atrophic changes, climactic sleep disturbances, depressive moods, osteoprotectio, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, neprholithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, stimulant, and tranquilizer; hemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; menstruation circulation regulating tablets; hormone preparations, hormone replacement medication; pharmaceutical preparations for sensory organs, namely, for use in ophthalmology, otolaryngology and dermatology; pharmaceutical preparations for regulation and strengthening of the immune system; pharmaceutical preparations for treating temporary relief of occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of dental bleaching gels, gum balms, medicated dental floss, medicated dental tapes, medicated dental ribbons, medicated teeth whitener gels, medicated toothpicks, fluoride chewing gum and chewable tablets for disclosing dental plaque and tartar; preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria, caries, diagnostic reagents for detecting derivatives from [ canes-causal ] * caries-casual * bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays and desensitizers; sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for health purposes; sanitary preparations for the treatment, cleaning and protection of the skin; dietary supplements in the form of tablets, drops, capsules, extract preparations, balms or in liquid form, containing plant extracts; dietetic substances adapted for medical use in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; food for medically restricted diets, food for diabetics, food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; vitamin and mineral supplements; food and food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for use in foods and dietary supplements for human consumption; dietetic food supplements; mineral food supplements, food supplements based on amino acids, minerals and/or trace elements; medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectantsSECTION 71 - CANCELLED—
009Downloadable electronic publications in the nature of magazines, journals, newsletters, periodicals, catalogs, brochures, manuals, leaflets, package inserts in the field of medicine and phytopharmacy, press releases featuring information on medicine and phytopharmacy; prerecorded magnetic data carriers featuring medicine and phytopharmacy; small weighing, measuring, signaling, checking and supervision apparatus, namely, pocket calculators, scales, balances, measuring rules, thermometers, computer storage devices, namely, flash drives, thumb drives, flash memory cards, memory cards and computer memory hardware to be used as an advertising medium; spectacles, namely, eyeglasses and goggles; protective helmets, namely, bicycle helmets; personal computers; DVD, CD, magnetic tape recorders and playersSECTION 71 - CANCELLED—
016Paper; cardboard; goods made from paper and cardboard, namely, paper bags, coasters, figures and works of art; printed matter, namely, books, magazines, journals, newspapers, periodicals, leaflets, reviews, manuals, catalogs and brochures in the fields of health and medicine; bookbinding material, namely, bookbindings; photographs; stationery; adhesives for stationery or household purposes; artists' materials, namely, artists' pastels, artists' pencils, artists' pens, painting sets for artists; paint brushes; typewriters; office requisites except furniture, namely, punches, staplers, erasers, desk pads, pencil sharpeners; printed instructional and teaching material, namely, instructional and teaching material in the field of medicine and phytopharmacy; paper bags, envelopes and pouches for packaging; plastic bags and bubble packs for packagingSECTION 71 - CANCELLED—
025Clothing for men, women and children, namely, T-shirts, pants, dresses, jackets, trousers, jumpers, socks; footwear for men, women and children; headgear for men, women and children, namely, hats, caps, headscarvesSECTION 71 - CANCELLED—
029Food additives for non-medical purposes, namely, food additives containing primarily fatty substances, greases and fatty acids, either singular or in combination, and also containing vitamins, minerals and trace elements; plant extracts for foodstuffs in the nature of food additives containing fatty acids and proteins to be used in food supplements and food, namely, soups, powdered nutritional supplement drink mixes and porridge; protein for use as food additive; proteins being food additives for human consumption containing fatty substances, fatty acids, vitamins, minerals and trace elements; food additives in the nature of fat acids made from meat, fish, fruits, vegetables, eggs, milk and edible oils and fats containing fatty substances, fatty acids, vitamins, minerals and trace elementsSECTION 71 - CANCELLED—
030Food additives for non-medical purposes, namely, food additives containing primarily carbohydrates and fiber, and also containing vitamins, minerals and trace elements, either singular or in combination; plant extracts and tinctures in liquid, solid or gaseous form to be used as flavorings in food and nutritional additives; herbal teas for food purposes; food additives in the nature of plant extracts used as flavoring in liquid, solid or gaseous form for foodstuffs, food supplements and food; foods and dietetic foods, namely, ready to eat cereal derived food barsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 4, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
May 4, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 2, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 21, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 21, 2016INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 21, 2016INPCINVALIDATION PROCESSED—
Jul 20, 2016INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 20, 2015C71TCANCELLED SECTION 71—
Jun 12, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 13, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 20, 2009COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 20, 2009PLGLASSIGNED TO PARALEGAL—
Oct 20, 2009CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 16, 2009CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jul 30, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 30, 2009FIMPFINAL DISPOSITION PROCESSED—
Jul 14, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 14, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 27, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 7, 2009NPUBNOTICE OF PUBLICATION—
Dec 23, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 23, 2008ALIEASSIGNED TO LIE—
Dec 13, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 11, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2008RFNPREFUSAL PROCESSED BY IB—
Jun 24, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 24, 2008RFRRREFUSAL PROCESSED BY MPU—
Jun 24, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 23, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2008DOCKASSIGNED TO EXAMINER—
Jun 23, 2008NWAPNEW APPLICATION ENTERED—
Jun 20, 2008LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Jun 19, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance